Central Laboratory, Peking University School and Hospital of Stomatology, Beijing, PR China.
National Clinical Research Center for Oral Diseases, Peking University School and Hospital of Stomatology, Beijing, PR China.
J Pathol. 2020 Aug;251(4):353-364. doi: 10.1002/path.5467. Epub 2020 Jul 9.
Tongue squamous cell carcinoma (TSCC) is an aggressive group of tumors characterized by high rates of regional lymph node metastasis and local recurrence. Emerging evidence has revealed genetic variations of TSCC across different geographical regions due to the impact of multiple risk factors such as chewing betel-quid. However, we know little of the mutational processes of TSCC in the Chinese population without the history of chewing betel-quid/tobacco. To explore the mutational spectrum of this disease, we performed whole-exome sequencing of sample pairs, comprising tumors and normal tissue, from 82 TSCC patients. In addition to identifying seven previously known TSCC-associated genes (TP53, CDKN2A, PIK3CA, NOTCH1, ASXL1, USH2A, and CSMD3), the analysis revealed six new genes (GNAQ, PRG4, RP1, ZNF16, NBEA, and PTPRC) that had not been reported previously in TSCC. Our in vitro experiments identified ZNF16 for the first time as a solid tumor associated gene to promote malignancy of TSCC cells. We also identified a microRNA (miR-585-5p) encoded by the 5q35.1 region and characterized it as a tumor suppressor by targeting SOX9. At least one non-silent mutation of genes involved in the 10 canonical oncogenic pathways (Notch, RTK-RAS, PI3K, Wnt, Cell cycle, p53, Myc, Hippo, TGFβ, and Nrf2) was found in 82.9% of cases. Collectively, our data extend the spectrum of TSCC mutations and define novel diagnosis markers and potential clinical targets for TSCC. © 2020 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
舌鳞状细胞癌(TSCC)是一组侵袭性肿瘤,其特点是区域淋巴结转移和局部复发率高。新出现的证据表明,由于咀嚼槟榔和烟草等多种危险因素的影响,不同地理区域的 TSCC 存在遗传变异。然而,我们对没有咀嚼槟榔和烟草历史的中国人群中 TSCC 的突变过程知之甚少。为了探索这种疾病的突变谱,我们对 82 名 TSCC 患者的肿瘤和正常组织样本进行了全外显子组测序。除了鉴定出七个先前已知的 TSCC 相关基因(TP53、CDKN2A、PIK3CA、NOTCH1、ASXL1、USH2A 和 CSMD3)外,该分析还揭示了六个以前未在 TSCC 中报道过的新基因(GNAQ、PRG4、RP1、ZNF16、NBEA 和 PTPRC)。我们的体外实验首次鉴定出 ZNF16 是一种与实体瘤相关的基因,可促进 TSCC 细胞的恶性转化。我们还发现了位于 5q35.1 区域的 microRNA(miR-585-5p),并通过靶向 SOX9 将其鉴定为一种肿瘤抑制因子。在 82.9%的病例中发现了至少一个涉及 10 个经典致癌途径(Notch、RTK-RAS、PI3K、Wnt、细胞周期、p53、Myc、Hippo、TGFβ 和 Nrf2)的基因的非沉默突变。总之,我们的数据扩展了 TSCC 突变谱,并定义了新的诊断标志物和 TSCC 的潜在临床靶点。